United Therapeutics (UTHR) Tops Q1 EPS by 7c, Miss on Revenues
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $543.11 +0.89%
EPS Growth %: +12.6%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +12.6%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.61, $0.07 better than the analyst estimate of $3.54. Revenue for the quarter came in at $370.5 million versus the consensus estimate of $398.18 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Increasing unusual option volume: UTHR DOMO IHI XIFR ALKS AM CTSH GDS DFTX
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
